STAT+: FDA is urged to move faster to list medicines withdrawn over safety concerns
Arguing patient safety is at risk, an advocacy group is urging the Food and Drug…
Category: Pharmaceuticals
STAT+: PhRMA chief talks strategy — and he’s surprisingly optimistic about drug pricing reform
WASHINGTON — Steve Ubl, who leads the drug industry lobbying powerhouse PhRMA, has a bold…
Opinion: Building the perfect wearable for clinical trials
The pace of innovation in wearable technology has never been faster. As often as once…
Opinion: No evidence that patents slow access to vaccines
At this point in the exhausting and deadly Covid-19 pandemic, people around the globe are…
STAT+: Europe tries to lower drug prices with small doses of transparency
For countries in Europe, negotiating a deal with a pharma company over drug prices is…
STAT+: Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time
In a bid to lower prescription drug costs, a federal agency is recommending pharmaceutical companies…
STAT+: Cavazzoni to take over influential spot atop FDA drug center
WASHINGTON — Patrizia Cavazzoni has been named the permanent leader of the FDA’s Center for…
Opinion: STAT+: Three steps toward creating a functioning U.S. biosimilars market
The development of safe, effective, and innovative biologic medicines is one of modern medicine’s far-reaching…
STAT+: Digital pharmacy startup Thirty Madison taps former Lilly exec as president
After nearly three decades working at two of the world’s pharmaceutical giants, Michelle Carnahan is…
Opinion: STAT+: Unprecedented development of Covid-19 vaccines, treatments points to biopharma’s future
Business as usual has not been the mantra for companies developing Covid-19 vaccines and drugs….
STAT+: Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug
Following a three-year probe, Merck (MRK) reached a deal with Austrian regulators to end a…
STAT+: A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs
After years of anticipation, the Brazilian Supreme Court is holding a hearing this week on…
STAT+: Lilly is a holdout among companies that agree to disclose when executive pay is clawed back
A coalition of institutional investors is pushing Eli Lilly to adopt a policy to disclose…
Opinion: Many hospitalized Covid-19 patients are given antibiotics. That’s a problem
As the Covid-19 pandemic continues into its second year, public health experts are increasingly concerned…
STAT+: Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment
A former top lobbyist at Eli Lilly (LLY) has filed a lawsuit accusing an executive…
.jpg)
Opinion: Money from opioid lawsuits is urgently needed now
Opioid companies are being forced to pay for their grave mistakes and misdeeds in helping…
STAT+: EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance
Amid rising concern over antibiotic resistance, a coalition of advocacy groups has filed a lawsuit…
STAT+: With Amazon and Ro on its heels, Uber expands its prescription delivery business
After steering into prescription delivery in two cities last summer with digital pharmacy startup NimbleRx,…
Opinion: STAT+: A Biden-Harris Biomanufacturing Initiative could increase supplies of vaccines, therapeutics in one fell swoop
The coronavirus pandemic is generating pressure on the manufacturing of vaccines and therapeutics. Every day…
José Baselga, renowned cancer researcher and AstraZeneca oncology R&D head, dies at 61
José Baselga, a storied oncology researcher and pharmaceutical executive whose discoveries helped pave the way…
STAT+: Pharma mergers face fresh scrutiny by a new international antitrust group
In response to a spate of pharmaceutical mergers, several antitrust regulators and enforcement agencies from…
STAT+: Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs
In the latest bid to pull back the curtain on pharmacy benefit managers, the Ohio…
STAT+: Pharmalittle: Biden urged by former FDA commissioners to pick agency chief; Lilly reports more positive data for Covid-19 drug
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
.jpg)
STAT+: Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal
Rise and shine, another busy day is on the way. We can tell it is…
STAT+: Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: STAT+: Making pharma’s post-Covid-19 future faster and smarter
There’s nothing like a global pandemic to force a reimagining of one’s business. What it…
STAT+: Physician and patients may prefer brand-name drugs, but they cost Medicare Part D a lot of money
Generic drugs may remain lower-cost alternatives to brand-name medicines, but the Medicare Part D program…
Opinion: The Biden administration’s pandemic agenda must not ignore superbugs
What if another devastating pandemic came on the heels of Covid-19? Unfortunately, that looks increasingly…
Opinion: STAT+: Create a U.S. Institute of Health Technology Assessment to preserve innovation and control costs
The public outcry to “do something” about health care spending keeps growing, but fear about…
Opinion: Why drug prescriptions should include diagnoses
The Covid-19 pandemic is teaching us many tragic lessons along with some instructive ones, like…
Opinion: Discarded drugs: a wasteful and costly problem that requires whole-of-government approaches
Controlling the rising costs of pharmaceuticals, particularly those administered by physicians, has been a top…
STAT+: Once again, the credit outlook for the pharmaceutical industry is negative
For the eighth consecutive year, the credit outlook for the pharmaceutical industry is negative and…
STAT+: Pharmalittle: FDA scientists say J&J Covid-19 shot is effective; vaccine makers predict big jump in deliveries this month
Good morning, everyone, and how are you today? We are doing just fine, thanks to…
Opinion: Three steps can help companies speed FDA approval of new drugs
Drug developers see Food and Drug Administration approval as a difficult uphill climb, requiring large…
STAT+: Access to heart drugs improves in middle-income countries, but still lags compared to wealthy nations
Middle-income countries have gained greater access to a variety of needed cardiovascular medicines, but remain…
STAT+: ‘Following the Amazon playbook’: As digital pharmacy grows more crowded, startups scramble to stand out
Ever since Amazon launched its digital pharmacy late last year, industry rivals have been worried…
STAT+: AbbVie smooths over a dispute about alleged theft of trade secrets for a new version of Botox
After two years of bickering, AbbVie (ABBV) and a marketing partner have settled a dispute…
STAT+: Federal judge nixes hospitals’ attempt to force HHS 340B crackdown
WASHINGTON — A federal judge ruled Thursday that it’s too early for hospitals to challenge…
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Several months after a splashy announcement, an ambitious pharmaceutical industry venture to tackle antibiotic resistance…
STAT+: Covid crushed in-person pharma sales. Tech is pitching itself as a solution
The pandemic grounded tens of thousands of pharmaceutical reps who usually roam the country urging…
STAT+: Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label
After years of litigation, a Hawaii court judge ordered Bristol Myers Squibb (BMY) and Sanofi…
Once again, senators want GAO to probe the role of PBMs in prescription drug pricing
In a bid to contain prescription drug prices, a pair of U.S. senators is re-introducing…
By looking the other way, pharma money helped fuel a toxic political atmosphere in the U.S.
As the impeachment trial for former President Trump plays out, the pharmaceutical industry can thank…
STAT+: Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection
A unit of Fresenius Kabi, a major supplier of infused and intravenously administered drugs, has…
STAT+: Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
Opinion: The Biden administration needs to look beyond ICER for evaluating drug therapies
As breakthrough drugs stream out of biopharmaceutical laboratories, how much they should cost and who…
STAT+: A move to crack down on human rights, environmental abuses puts European pharma on notice
A new European plan to develop legislation to hold companies accountable for human rights abuses…
STAT+: WTO is urged to ease trade rules so low-income countries can access drugs and vaccines
More than 100 advocacy groups from dozens of countries are urging the World Trade Organization…
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Jazz Pharmaceuticals said Wednesday that it is acquiring GW Pharma, adding an approved childhood epilepsy…
STAT+: PhRMA sues to block Trump administration 340B rule
WASHINGTON — The trade group for the pharmaceutical industry on Friday sued to block a …